Our findings are in line with these reports, demonstrating that EPHB2 can influence migration and invasion also in NSCLC, supporting the notion that this receptor has a pro-oncogenic role also in this cancer type. The gene discussed is EPHB2; the disease is non-small cell lung carcinoma.